&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-12-11, 20:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-10-31, 18:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-09-18, 17:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-06-06, 14:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-05-23, 20:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-05-22, 23:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-05-16, 08:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-23, 18:00
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-16, 16:04
Medigene to present first pre-clinical data for MDG1015
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the...
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2023-03-09, 22:25
2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund
CHICAGO and NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) -- As therapeutic applications of psychedelics gain more traction in the mainstream consciousness,...
